SEA version 4.0: a major expansion and update of the Super-Enhancer Archive
Nucleic Acids Research · 2026
DOI: 10.1093/nar/gkaf1114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2026. Verfasst von Bowen Shi und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Technology, Faculty of Life Sciences and Medicine, Harbin Institute of Technology, Harbin 150001, China. Hauptthemen laut MEDLINE: Enhancer Elements, Genetic, Databases, Genetic, Software. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Qiqihar City Joint Guidance Project of Science and Technology Program.
Abstract (Originalsprache)
Super-enhancers (SEs) are pivotal epigenetic regulatory elements that profoundly influence cell fate and disease. We herein present an updated SEA version 4.0, a systematic platform designed to elucidate the roles of SEs. A uniform computational pipeline was established to identify SEs based on five key histone marks, using H3K27ac, BRD4, p300, Med1, and the newly added H3K4me1, across 14 species. 496 071 SEs and 29 584 078 enhancers have been stored in the database. It provides extensive genome annotations, including nearby genes, transcription factor binding sites, chromatin accessibility, and other gene regulation signatures. SEA version 4.0 has also achieved functional enrichment analysis of SEs. And a Shannon entropy-based algorithm is employed to identify specific SEs. Furthermore, SEA version 4.0 introduces an interactive regulatory network that incorporates SEs, enhancers, transcription factors, and proximal genes for human and mouse. Additionally, a cell-specific SE detector is provided, designed for cancer research by leveraging scRNA-seq data from 12 cancer and normal samples to explore cell-type-specific SEs. The performance interaction and visualization of SEA version 4.0 enable genomic and cross-species comparisons, revealing complex genomic interactions and becoming an indispensable resource for decoding the mechanisms of SE in development and disease. Access freely at http://sea4.edbc.org.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Life Science and Technology, Faculty of Life Sciences and Medicine, Harbin Institute of Technology, Harbin 150001, China.
- College of Pathology, Qiqihar Medical University, Qiqihar 161042, China.
- The Fourth Hospital of Harbin Medical University, Harbin 150080, China.
ORCID-Profile: Yan Zhang
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Qiqihar City Joint Guidance Project of Science and Technology Program
Zitieren
APA
Shi, B., Zhao, J., Li, Y., Zhang, C., Deng, L., Ji, C., Wang, H., Zhai, R., Feng, T., Zhang, Y., & Gu, Y. (2026). SEA version 4.0: a major expansion and update of the Super-Enhancer Archive. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf1114
Vancouver
Shi B, Zhao J, Li Y, Zhang C, Deng L, Ji C, et al. SEA version 4.0: a major expansion and update of the Super-Enhancer Archive. Nucleic Acids Research. 2026. doi:10.1093/nar/gkaf1114
BibTeX
@article{Shi2026,
author = {Shi, Bowen and Zhao, Jiyun and Li, Yu and Zhang, Chenye and Deng, Longhao and Ji, Chengzhi and Wang, Hongli and Zhai, Ruiyang and Feng, Tao and Zhang, Yan and Gu, Yue},
title = {SEA version 4.0: a major expansion and update of the Super-Enhancer Archive},
journal = {Nucleic Acids Research},
year = {2026},
doi = {10.1093/nar/gkaf1114}
}
EUVIMED